Patents by Inventor Jerome Parcq

Jerome Parcq has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230263870
    Abstract: The present invention relates to slow release plasminogen activator composition. The present invention also relates to the therapeutic use of said composition, in particular in thrombotic or haemorrhagic disease.
    Type: Application
    Filed: May 11, 2021
    Publication date: August 24, 2023
    Inventors: Jérôme PARCQ, Christophe GAUDIN, Estelle LOUET, Marie-Julie GUICHARD
  • Patent number: 9732334
    Abstract: The present invention relates to mutated tissue plasminogen activators, and their use for treating thrombotic diseases.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: August 15, 2017
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Caen Basse Normandie
    Inventors: Denis Vivien, Jerome Parcq
  • Publication number: 20160194623
    Abstract: The present invention relates to mutated tissue plasminogen activators, and their use for treating thrombotic diseases.
    Type: Application
    Filed: December 17, 2015
    Publication date: July 7, 2016
    Applicants: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Caen Basse Normandie
    Inventors: Denis VIVIEN, Jerome PARCQ
  • Patent number: 9249406
    Abstract: The present invention relates to mutated tissue plasminogen activators, and their use for treating thrombotic diseases.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: February 2, 2016
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Caen Basse Normandie
    Inventors: Denis Vivien, Jerome Parcq
  • Publication number: 20150050264
    Abstract: The present invention relates to mutated tissue plasminogen activators, and their use for treating thrombotic diseases.
    Type: Application
    Filed: September 7, 2012
    Publication date: February 19, 2015
    Applicant: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Denis VIVIEN, Jerome PARCQ, Denis VIVIEN, Jerome PARCQ
  • Publication number: 20140212406
    Abstract: The present invention relates to mutated tissue plasminogen activators, and their use for treating thrombotic diseases.
    Type: Application
    Filed: September 7, 2012
    Publication date: July 31, 2014
    Applicant: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Denis Viven, Jerome Parcq